La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Viscofan Bilan de santé
Santé financière contrôle des critères 5/6
Viscofan possède un total de capitaux propres de €916.8M et une dette totale de €267.4M, ce qui porte son ratio d'endettement à 29.2%. Son actif total et son passif total sont €1.4B et de €509.7M. L'EBIT de Viscofan est €185.9M ce qui fait que son ratio de couverture des intérêts 27. Elle dispose de liquidités et de placements à court terme de €52.2M.
Informations clés
29.2%
Ratio d'endettement
€267.38m
Dette
Ratio de couverture des intérêts | 27x |
Argent liquide | €52.18m |
Fonds propres | €916.78m |
Total du passif | €509.65m |
Total des actifs | €1.43b |
Mises à jour récentes de la santé financière
Is Viscofan (BME:VIS) Using Too Much Debt?
Dec 21Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet
Sep 20Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly
May 25Is Viscofan (BME:VIS) Using Too Much Debt?
Jan 07Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet
Sep 01Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?
Mar 25Recent updates
Here's Why We Think Viscofan (BME:VIS) Might Deserve Your Attention Today
Aug 17Viscofan, S.A. (BME:VIS) Interim Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 02Viscofan (BME:VIS) Shareholders Will Want The ROCE Trajectory To Continue
Jun 26Viscofan, S.A. (BME:VIS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Apr 20Why We Think Viscofan, S.A.'s (BME:VIS) CEO Compensation Is Not Excessive At All
Apr 11Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 38% Undervaluation?
Apr 04Some Shareholders Feeling Restless Over Viscofan, S.A.'s (BME:VIS) P/E Ratio
Mar 18Slowing Rates Of Return At Viscofan (BME:VIS) Leave Little Room For Excitement
Jan 17Is Viscofan (BME:VIS) Using Too Much Debt?
Dec 21Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 37% Undervaluation?
Nov 15Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet
Sep 20Returns On Capital At Viscofan (BME:VIS) Have Stalled
Aug 29Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 32% Undervaluation?
Aug 11Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly
May 25Viscofan's (BME:VIS) Dividend Will Be Increased To €0.4374
May 04Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching
Apr 24The Returns At Viscofan (BME:VIS) Aren't Growing
Mar 02Estimating The Intrinsic Value Of Viscofan, S.A. (BME:VIS)
Feb 16Is Viscofan (BME:VIS) Using Too Much Debt?
Jan 07Returns On Capital At Viscofan (BME:VIS) Have Stalled
Nov 29Viscofan, S.A.'s (BME:VIS) Intrinsic Value Is Potentially 77% Above Its Share Price
Nov 11Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet
Sep 01Viscofan (BME:VIS) Has Some Way To Go To Become A Multi-Bagger
Aug 03Viscofan's (BME:VIS) Returns Have Hit A Wall
May 03Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?
Mar 25Is Viscofan, S.A. (BME:VIS) Trading At A 38% Discount?
Mar 06Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching
Jan 15Returns At Viscofan (BME:VIS) Appear To Be Weighed Down
Dec 29Viscofan (BME:VIS) Has A Rock Solid Balance Sheet
Nov 24Is Viscofan, S.A. (BME:VIS) Trading At A 24% Discount?
Oct 10With EPS Growth And More, Viscofan (BME:VIS) Is Interesting
Sep 23Returns On Capital At Viscofan (BME:VIS) Have Stalled
Aug 19Viscofan (BME:VIS) Has A Rock Solid Balance Sheet
Aug 03A Look At The Fair Value Of Viscofan, S.A. (BME:VIS)
May 17Viscofan (BME:VIS) Could Easily Take On More Debt
Apr 07Should We Be Excited About The Trends Of Returns At Viscofan (BME:VIS)?
Mar 04Here's What Viscofan, S.A.'s (BME:VIS) Shareholder Ownership Structure Looks Like
Feb 17Viscofan, S.A.'s (BME:VIS) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Feb 02A Look At The Intrinsic Value Of Viscofan, S.A. (BME:VIS)
Jan 18Why Viscofan's (BME:VIS) CEO Pay Matters
Dec 26Income Investors Should Know That Viscofan, S.A. (BME:VIS) Goes Ex-Dividend Soon
Dec 13Should Viscofan, S.A. (BME:VIS) Be Part Of Your Dividend Portfolio?
Dec 04The Returns At Viscofan (BME:VIS) Provide Us With Signs Of What's To Come
Nov 19Analyse de la situation financière
Passif à court terme: Les actifs à court terme de VIS ( €800.3M ) dépassent ses passifs à court terme ( €372.0M ).
Passif à long terme: Les actifs à court terme de VIS ( €800.3M ) dépassent ses passifs à long terme ( €137.7M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de VIS ( 23.5% ) est considéré comme satisfaisant.
Réduire la dette: Le ratio d'endettement de VIS est passé de 19.6% à 29.2% au cours des 5 dernières années.
Couverture de la dette: La dette de VIS est bien couverte par le flux de trésorerie opérationnel ( 79.6% ).
Couverture des intérêts: Les paiements d'intérêts de VIS sur sa dette sont bien couverts par l'EBIT ( 27 x couverture).